BTIG Reiterates Buy on Praxis Precision Medicine, Maintains $810 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 85.8%

Neg 0% Neu 85.8% Pos 0%

BTIG analyst Kambiz Yazdi reiterates Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and maintains $810 price target.